A calcium channel
blocker (CCB) is a drug that prevents calcium from entering cells and has its chief effects on vascular smooth muscle and the heart.
A total of 617 patients were users of calcium channel
The National Heart, Lung, and Blood Institute (NHBLI), which had funded the study, was quick to note that even if the study's results are confirmed by further, more definitive studies, the risk of heart attack would be low for those taking calcium channel
Xdynia is a spin-out company of Tau Therapeutics LLC, a world leader in developing T-type calcium channel
products for the treatment of cancer.
Treatment with calcium channel
blockers for rate control in atrial fibrillation should Le considered more often in patients not needing a beta-blocker--that is, in patients without systolic heart failure or coronary heart disease," she said at the meeting.
People taking a widely used group of drugs to treat high blood pressure known as calcium channel
blockers also appear to be cutting their risk of developing Parkinson's disease, according to a recent study.
Q: I take a blood pressure medication called nifedipine, a calcium channel
Some channels open when they receive a chemical or environmental signal, such as the recently discovered calcium channel
that responds to cold temperatures (SN: 2/16/02, p.
The conference, "Calcium Channels
: Critical Targets of Toxicants and Diseases," brought together experts in a variety of disciplines to discuss our current knowledge of calcium channel
structure and function, channel regulation by intracellular signaling molecules, and the effects of mutations, aging, and toxicants on channel functions.
A diagnosis of hypertension is hard enough for many patients to swallow, but a lifetime of calcium channel
blocker therapy can be difficult to stomach--literally Calcium channel
blockers (CCBs) appear to trigger or aggravate gastro-esophageal reflux disorder, Aileen Luzier, Pharm.
Up to 20 percent of patients taking calcium channel
blockers for high blood pressure and heart disease suffer gum swelling.
Tau Therapeutics LLC, a company repositioning and developing T-type calcium channel
inhibitors for the treatment of solid tumors, announced today that President and CEO Andrew J.